v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (26,072) $ (45,188)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 24,582 28,790
Amortization of debt issuance costs 303 505
Amortization of debt discount (1,099) (2,894)
Provision for doubtful accounts 2,233 1,136
(Gain) loss on sale or disposal of assets or stations (458) 122
Impairment of assets held for sale 0 1,420
Deferred income taxes 1,165 1,722
Stock-based compensation expense 472 1,423
Non-cash interest expense on financing liabilities 1,283 1,636
Non-cash imputed rental income (2,481) (2,510)
Non-cash reorganization items, net (32,872) 0
Changes in assets and liabilities (excluding acquisitions and dispositions):    
Accounts receivable 18,782 13,089
Trade receivable (256) (2,600)
Prepaid expenses and other current assets (8,213) (2,216)
Operating leases, net (826) (719)
Other assets (3,039) 2,787
Accounts payable and accrued expenses 12,318 (5,365)
Trade payable 856 635
Other liabilities 380 700
Net cash used in operating activities (12,942) (7,527)
Cash flows from investing activities:    
Proceeds from sale of assets or stations 661 498
Proceeds from insurance reimbursement 276 0
Capital expenditures (7,093) (11,068)
Net cash used in investing activities (6,156) (10,570)
Cash flows from financing activities:    
Borrowings under the 2020 revolving credit facility 2,028 55,000
Adequate protection payments on 2020 revolving credit facility (458) 0
Shares returned in lieu of tax payments (24) (274)
Repayments of financing liabilities (3,324) (3,161)
Repayments of finance lease obligations (568) (559)
Proceeds from tenant improvement reimbursement 576 0
Net cash used in financing activities (1,770) 51,006
Decrease in cash, cash equivalents and restricted cash (20,868) 32,909
Cash, cash equivalents and restricted cash at beginning of period 81,979 63,836
Cash, cash equivalents and restricted cash at end of period $ 61,111 $ 96,745